BCPC
BALCHEM CORP
+0.16 (+0.09%)167.76USD42.7K成交股數5.3B市值32.1本益比(近四季)4.9股價營收比+11.2%營收年增(近四季)2026-10-20下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 284M+11% | 271M+8% | 264M+10% | 268M+12% | 255M+9% | 251M+5% | 240M+5% | 240M+4% | 234M | 240M | 229M | 230M |
| 營業成本 | 180M | 170M | – | 172M | 162M | 162M | – | 155M | 151M | 158M | – | 153M |
| 毛利 | 104M+11% | 101M+15% | 93.9M+9% | 95.5M+12% | 93.1M+12% | 88.2M+8% | 86.3M+15% | 85.4M+12% | 83.0M | 81.5M | 75.0M | 76.5M |
| 毛利率 | 36.5% | 37.3% | 35.6% | 35.7% | 36.4% | 35.2% | 36.0% | 35.6% | 35.5% | 34.0% | 32.8% | 33.3% |
| 研發費用 | 4.5M | 5.9M | – | 4.5M | 4.3M | 4.7M | – | 4.3M | 3.9M | 4.1M | – | 3.9M |
| 銷售管理費用 | 18.8M | 18.5M | – | 17.3M | 18.1M | 15.6M | – | 17.5M | 15.3M | 17.5M | – | 10.8M |
| 營業利益 | 59.2M+15% | 55.6M+9% | – | 54.6M+14% | 51.4M+12% | 51.0M+22% | – | 48.0M+10% | 45.8M | 41.7M | – | 43.6M |
| 營業利益率 | 20.9% | 20.5% | – | 20.4% | 20.1% | 20.4% | – | 20.0% | 19.6% | 17.4% | – | 19.0% |
| 稅後淨利 | 44.6M+17% | 40.3M+9% | 39.2M+17% | 40.3M+19% | 38.3M+19% | 37.1M+28% | 33.6M+26% | 33.8M+16% | 32.1M | 29.0M | 26.6M | 29.1M |
| 淨利率 | 15.7% | 14.9% | 14.9% | 15.1% | 15.0% | 14.8% | 14.0% | 14.1% | 13.7% | 12.1% | 11.7% | 12.6% |
| 稀釋 EPS | 1.39+19% | 1.25+11% | 1.21+17% | 1.24+20% | 1.17+19% | 1.13+27% | 1.03+26% | 1.03+14% | 0.98 | 0.89 | 0.82 | 0.90 |
| 稀釋股數 | 32.2M | 32.3M | – | 32.6M | 32.7M | 32.8M | – | 32.8M | 32.6M | 32.6M | – | 32.5M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 63.2M | 72.9M | 74.6M | 65.1M | 65.4M | 49.9M | 49.5M | 73.7M | 63.7M | 60.3M | 64.4M | 77.0M |
| 應收帳款 | 149M | 154M | 144M | 132M | 136M | 130M | 120M | 121M | 123M | 140M | 125M | 129M |
| 存貨 | 162M | 147M | 131M | 132M | 148M | 145M | 131M | 119M | 117M | 110M | 110M | 116M |
| 總資產 | 1.7B | 1.7B | 1.7B | 1.7B | 1.7B | 1.6B | 1.6B | 1.6B | 1.6B | 1.6B | 1.6B | 1.6B |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 385M | 409M | 429M | 363M | 410M | 409M | 425M | 420M | 463M | 510M | 543M | 578M |
| 股東權益 | 1.3B | 1.3B | 1.3B | 1.3B | 1.3B | 1.2B | 1.1B | 1.2B | 1.1B | 1.1B | 1.1B | 1.0B |
| 負債比 | 22.8% | 24.1% | 25.4% | 21.9% | 24.5% | 25.3% | 27.0% | 26.3% | 29.4% | 32.1% | 34.0% | 36.1% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 40.1M+10% | – | – | – | 36.5M+9% | – | – | – | 33.4M | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | 12.2M | 12.5M | – | 11.6M | 11.4M | 11.0M | – | 10.9M | 12.5M | 13.7M | – | 13.8M |
| 買回庫藏股 | – | 15.7M | – | – | – | 5.3M | – | – | – | 5.2M | – | – |
| 現金股利 | – | 30.8M | – | – | – | 28.3M | – | – | – | 25.6M | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 1.0B
| Human Nutrition And Health | 659M | 63.9% | +9.9% |
|---|---|---|---|
| Animal Nutrition And Health | 231M | 22.4% | +7.5% |
| Specialty Products | 141M | 13.7% | +6.2% |
地區2025 年度 · 1.0B
| 美國 | 759M | 73.2% | +5.0% |
|---|---|---|---|
| 美國以外 | 278M | 26.8% | +20.5% |
產品／服務2025 年度 · 1.0B
| Product Sales | 1.0B | 99.8% | +8.8% |
|---|---|---|---|
| Royalty | 1.9M | 0.2% | +8.8% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 1.0B | +8.8% | 155M | 14.9% | 4.75 | – |
| FY2024 | 954M | +3.4% | 128M | 13.5% | 3.93 | – |
| FY2023 | 922M | -2.1% | 109M | 11.8% | 3.35 | – |
| FY2022 | 942M | +17.9% | 105M | 11.2% | 3.25 | 89.5M |
| FY2021 | 799M | +13.6% | 96.1M | 12.0% | 2.94 | 124M |
| FY2020 | 704M | +9.3% | 84.6M | 12.0% | 2.60 | 118M |
| FY2019 | 644M | +0.0% | 79.7M | 12.4% | 2.45 | 98.7M |
| FY2018 | 644M | – | 78.6M | 12.2% | 2.42 | 99.5M |